ストックスクリーナーアプリを入手
0.00
100.00%
-0.765
前日終値:
$0.765
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$3.71M
収益：
-
当期純損益:
-
株価収益率:
0.00
EPS:
-0.604
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$3.59
Genetic Technologies Ltd Adr Stock (GENE) Company Profile
GENE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GENE
Genetic Technologies Ltd Adr
|
0.00 | 3.71M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Genetic Technologies Ltd Adr (GENE) 最新ニュース
SOHM, Inc. Secures Key Patent for Revolutionary Gene Editing Technology - Sangri Today Spotlight
Genetic Technologies files regulatory report - Investing.com India
Genetic Technologies appoints voluntary administrators By Investing.com - Investing.com South Africa
Genetic Technologies appoints voluntary administrators - Investing.com India
10 Biggest Biotechnology Companies - Investopedia
Japan Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
Genetic Technologies faces NASDAQ equity shortfall - Investing.com India
Genetic Technologies joins "CancerIQ" platform - Investing.com
Stocks of the Hour: DroneShield, Genetic Technologies, Cauldron Energy - ShareCafe
Genetic Technologies faces Nasdaq noncompliance issue - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue By Investing.com - Investing.com UK
Genetic Technologies launches geneType on EasyDNA platform - Investing.com
Ascendis Pharma (ASND) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
Genetic Technologies sets sights on U.S. market growth - Investing.com India
Genetic Technologies names new CFO and Company Secretary - Investing.com India
Genetic Technologies Ltd. ADR (GENE) Stock: A Year of Market Fluctuations - The InvestChronicle
India Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
Genetic Technologies CFO Steps Down By Investing.com - Investing.com India
HEICO shares target raised, keeps Buy rating on strong outlook By Investing.com - Investing.com India
Barclays maintains FedEx overweight rating, $350 target By Investing.com - Investing.com
Energizer stock PT raised to $375 at Deutsche Bank, reflecting revenue growth By Investing.com - Investing.com
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewswire Inc.
Genetic Technologies to Host Investor Webinar By Investing.com - Investing.com India
Mastercard shareholders vote on board, executive pay, and proposals By Investing.com - Investing.com
Insmed shares target lifted by Evercore ISI on brensocatib optimism By Investing.com - Investing.com UK
Inozyme Pharma reports voting results, re-elects directors By Investing.com - Investing.com
BM Technologies reports annual meeting results By Investing.com - Investing.com
Gilead's HIV prevention trial shows promise with zero infections By Investing.com - Investing.com
FSN E-commerce stock upgraded by ICICI Securities citing growth focus By Investing.com - Investing.com
Crest Nicholson shares target reduced by Deutsche Bank, margin pressures cited By Investing.com - Investing.com
Genetic Technologies Ltd. ADR (GENE) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Li-Cycle holdings director Mark Wellings sells shares worth over $36,000 - Investing.com
Hesai Group CFO Louis T. Hsieh steps down By Investing.com - Investing.com
Anocca AB Licenses Gene Editing Technology from EmendoBio Inc. - Yahoo Finance
6 Best Genomics Stocks to Buy in 2024 - The Motley Fool
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes - Frontiers
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change - Yahoo Finance
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it - Stockhead
Gene Slade’s Journey in Mastering Sales and Transforming Businesses - CEOWORLD magazine
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead
The 20 European Biotech Companies to Watch in 2022 - Labiotech.eu
Syncona to acquire Applied Genetic Technologies Corporation - BioPharma-Reporter.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Start of demonstration experiment of algal breeding technology to solve climate change issues -Aiming to establish the world's first useful algae breeding technology by introducing genetic mutation through neutron irradiation- - NTT
Tech - GSK
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit - Stockhead
Pharmacogenomics Market Dynamics, Size, Forecast, 2022-2030 - P&S Intelligence
Check up: 78 biotech companies rocked the boat this week but only one has real news - Stockhead
Genetic Technologies Ltd.ADR Shares Fall 0.8% Below Previous 52-Week LowMarket Mover - Nasdaq
Genetic Technologies Ltd Adr (GENE) 財務データ
Genetic Technologies Ltd Adr (GENE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.72%
大文字化:
|
ボリューム (24 時間):